Laura S Samples
National Heart, Lung, and Blood Institute (NHLBI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Laura S Samples as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:14 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07882173 · Epcoritamab as Consolidative Therapy for Waldenstr(SqrRoot)(Delta)m Macroglobulinemia (WM) Treated With a Bruton Tyrosine Kinase Inhibitor (BTKi)National Heart, Lung, and Blood Institute (NHLBI) · not yet recruiting · Waldenstrom Macroglobulinemia · principal investigator
- Ph2NCT07796373 · Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inhibitor or Pirtobrutinib and Previously Treated With a BCL2 InhibitorNational Heart, Lung, and Blood Institute (NHLBI) · not yet recruiting · Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia · principal investigator
- Early Ph1NCT07428707 · Immune Profiling of CLL/SLL Treated With First-Line PirtobrutinibNational Heart, Lung, and Blood Institute (NHLBI) · recruiting · Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 20:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.